Ostatní
Návod 
Abbott Laboratories
ABT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
218.3B
Obrat
44B
Zisk
7B
Aktiva
84B
Dluh
13B
ROE
0%
ROA
0%
PE
28
PS
4
Cena 1R
114-141
⌀ Cena
129.88
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
15-04-2026
Nadcházející dividenda
15-04-2026
Profil
Abbott Laboratories společně se svými dceřinými společnostmi objevuje, vyvíjí, vyrábí a prodává zdravotnické produkty po celém světě. Působí ve čtyřech segmentech: zavedené farmaceutické výrobky, diagnostické výrobky, výživné výrobky a zdravotnické prostředky. Zavedený segment farmaceutických výrobků poskytuje generická léčiva pro léčbu pankreatické exokrinní insuficience, syndromu dráždivého střeva nebo žlučových křečí, intrahepatální cholestázy nebo depresivních symptomů, gynekologické poruchy, hormonální substituční terapie, dyslipidemie, hypertenze, hypotyreózy, Ménièrovy choroby a vestibulárního vertiga, bolesti, horečky, zánětu a migrény, a dále poskytuje antiinfekční klaritromycin, vakcínu proti chřipce a přípravky pro regulaci fyziologického rytmu tlustého střeva. Segment Diagnostické produkty nabízí laboratorní systémy v oblasti imunoanalýzy, klinické chemie, hematologie a transfuze; molekulární diagnostické systémy, které automatizují extrakci, čištění a přípravu DNA a RNA ze vzorků pacientů, jakož i detekci a měření infekčních činitelů; systémy péče; náplně pro testování krve; rychlé diagnostické produkty pro testování bočního toku; molekulární testování v místě péče pro HIV, SARS-CoV-2, chřipku A a B, RSV a strep A; kardiometabolické testovací systémy; testování na přítomnost léčiv a alkoholu a dálkové monitorování pacienta a sebemonitorování spotřebitele testovací systémy; a informační a automatizační řešení pro použití v laboratořích. Segment nutričních produktů poskytuje pediatrické a dospělé nutriční produkty. Segment zdravotnických prostředků nabízí řízení rytmu, elektrofyziologii, srdeční selhání, cévní a strukturální srdeční zařízení pro léčbu kardiovaskulárních onemocnění a výrobky pro léčbu diabetu, stejně jako neuromodulační zařízení pro léčbu chronické bolesti a pohybových poruch. Abbott Laboratories byla založena v roce 1888 a sídlí v severním Chicagu v Illinois.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
114000
Založení
1980-03-17
Podobné společnosti
$ 45.70
+ $ 0.02
$ 86.23
- $ 0.05
$ 574.83
+ $ 2.42
$ 126.72
+ $ 0.37
$ 99.98
- $ 0.05
$ 92.21
+ $ 0.01
$ 353.94
- $ 2.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 44.33 | 44.33 | 41.95 | 40.11 | 43.65 | 43.08 | 34.61 | 31.90 | 30.58 | 27.39 | 20.85 | 20.41 | 20.25 | 21.85 | 39.87 | 38.85 | 35.17 | |
| Cost of Revenues | 19.72 | 19.72 | 20.63 | 17.98 | 19.14 | 18.54 | 15.00 | 13.23 | 12.71 | 12.34 | 9.02 | 8.75 | 9.22 | 10.04 | 15.12 | 15.54 | 14.67 | |
| Gross Profit | 24.61 | 24.61 | 21.33 | 22.13 | 24.51 | 24.54 | 19.61 | 18.67 | 17.87 | 15.05 | 11.83 | 11.66 | 11.03 | 11.81 | 24.75 | 23.31 | 20.50 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 11.46 | 11.37 | 11.14 | 10.36 | 10.97 | 10.64 | 10.38 | 9.96 | 10.24 | 10.14 | |
| Cost of Revenues | 4.92 | 5.03 | 4.85 | 4.91 | 5.38 | 5.21 | 5.07 | 4.94 | 4.98 | 4.61 | |
| Gross Profit | 6.54 | 6.34 | 6.29 | 5.44 | 5.60 | 5.43 | 5.31 | 5.02 | 5.26 | 5.54 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 2.74 | 2.89 | 2.74 | 2.42 | 2.44 | 2.30 | 2.24 | 1.42 | 1.41 | 1.35 | 1.45 | 4.32 | 4.80 | 3.73 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 10.95 | 11.25 | 11.32 | 9.70 | 9.77 | 9.74 | 9.12 | 6.67 | 6.79 | 6.53 | 6.94 | 12.06 | 12.76 | 10.38 | |
| Depreciation & Amortization | 2.75 | 2.75 | 3.22 | 3.24 | 2.33 | 2.32 | 2.24 | 2.13 | 2.18 | 1.98 | 0.55 | 0.60 | 0.56 | 0.79 | 2.78 | 3.04 | 2.62 | |
| Total Operating Expenses | 16.59 | 16.59 | 14.47 | 15.66 | 16.15 | 16.11 | 14.25 | 14.14 | 14.22 | 13.33 | 8.64 | 8.79 | 8.43 | 9.18 | 16.38 | 17.56 | 14.10 | |
| Operating Income | 8.05 | 8.05 | 6.83 | 6.48 | 8.36 | 8.43 | 5.36 | 4.53 | 3.65 | 1.73 | 3.19 | 2.87 | 2.60 | 2.63 | 8.09 | 5.75 | 6.09 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.69 | 0.67 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.70 | 2.60 | ||
| Depreciation & Amortization | 0.42 | 0.79 | 0.78 | 0.76 | 0.81 | 0.80 | 0.81 | 0.81 | 0.81 | 0.82 | ||
| Total Operating Expenses | 4.29 | 4.31 | 4.24 | 3.76 | 3.61 | 3.61 | 3.62 | 3.64 | 3.39 | 3.80 | ||
| Operating Income | 2.25 | 2.06 | 2.05 | 1.69 | 1.99 | 1.82 | 1.69 | 1.39 | 1.86 | 1.77 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.23 | 0.23 | 0.34 | 0.39 | 0.18 | 0.04 | 0.05 | 0.09 | 0.11 | 0.12 | 0.10 | 0.11 | 0.08 | 0.07 | 0.08 | 0.09 | 0.11 | |
| Interest Expense | 0.34 | 0.34 | 0.60 | 0.64 | 0.38 | 0.49 | 0.50 | 0.58 | 0.72 | 0.78 | 0.33 | 0.06 | 0.07 | 0.09 | 0.51 | 0.53 | 0.55 | |
| Other Expense | 0.42 | 0.42 | 0.19 | 0.19 | -0.06 | -0.21 | -0.39 | -0.46 | -0.06 | 1.29 | -1.44 | 0.37 | -0.01 | -0.02 | -1.60 | -0.11 | -0.39 | |
| IBT | 8.47 | 8.47 | 7.01 | 6.66 | 8.31 | 8.21 | 4.97 | 4.08 | 2.87 | 2.23 | 1.41 | 3.18 | 2.52 | 2.52 | 6.26 | 5.20 | 5.71 | |
| Income Tax Expense | 1.94 | 1.94 | -6.39 | 0.94 | 1.37 | 1.14 | 0.50 | 0.39 | 0.54 | 1.88 | 0.35 | 0.58 | 0.80 | 0.14 | 0.30 | 0.47 | 1.09 | |
| Net Income | 6.52 | 6.52 | 13.40 | 5.72 | 6.93 | 7.07 | 4.50 | 3.69 | 2.37 | 0.48 | 1.40 | 4.42 | 2.28 | 2.58 | 5.96 | 4.73 | 4.63 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.08 | 0.07 | 0.08 | 0.09 | 0.09 | 0.08 | 0.08 | 0.09 | 0.07 | ||
| Interest Expense | 0.04 | 0.04 | 0.12 | 0.13 | 0.15 | 0.17 | 0.17 | 0.12 | 0.24 | 0.17 | ||
| Other Expense | 0.11 | 0.12 | 0.10 | 0.09 | 0.04 | 0.12 | -0.08 | 0.05 | 0.43 | 0.02 | ||
| IBT | 2.36 | 2.18 | 2.15 | 1.78 | 2.03 | 1.94 | 1.61 | 1.44 | 1.80 | 1.67 | ||
| Income Tax Expense | 0.58 | 0.54 | 0.37 | 0.45 | -7.20 | 0.29 | 0.31 | 0.21 | 0.20 | 0.24 | ||
| Net Income | 1.78 | 1.64 | 1.78 | 1.33 | 9.23 | 1.65 | 1.30 | 1.23 | 1.59 | 1.44 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $3.30 | $3.91 | $4.01 | $2.54 | $2.09 | $1.35 | $0.27 | $0.95 | $3.00 | $1.51 | $1.66 | $3.78 | $3.01 | $2.99 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $3.27 | $3.88 | $3.94 | $2.50 | $2.06 | $1.34 | $0.27 | $0.94 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 | |
| Shares Outstanding | 1.75 | 1.75 | 1.73 | 1.73 | 1.77 | 1.76 | 1.77 | 1.76 | 1.76 | 1.74 | 1.47 | 1.47 | 1.51 | 1.55 | 1.58 | 1.57 | 1.55 | |
| Diluted Shares Outstanding | 1.75 | 1.75 | 1.75 | 1.75 | 1.79 | 1.79 | 1.79 | 1.78 | 1.77 | 1.75 | 1.48 | 1.51 | 1.53 | 1.57 | 1.59 | 1.57 | 1.56 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.92 | $0.83 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.91 | $0.82 | ||
| Shares Outstanding | 1.75 | 1.75 | 1.74 | 1.75 | 1.73 | 1.73 | 1.73 | 1.73 | 1.73 | 1.74 | ||
| Diluted Shares Outstanding | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 6.99 | 7.62 | 6.90 | 9.88 | 9.80 | 6.84 | 3.86 | 3.84 | 9.41 | 18.62 | 5.00 | 4.06 | 3.48 | 10.80 | 6.81 | 3.65 | |
| Short Term Investments | 0.23 | 0.35 | 0.38 | 0.29 | 0.45 | 0.31 | 0.28 | 0.24 | 0.20 | 0.16 | 1.12 | 0.40 | 4.62 | 4.37 | 1.28 | 1.80 | |
| Total Cash & ST Investments | 7.22 | 7.97 | 7.28 | 10.17 | 10.25 | 7.15 | 4.14 | 4.09 | 9.61 | 18.78 | 6.13 | 4.46 | 8.10 | 15.17 | 8.10 | 5.45 | |
| Accounts Receivable | 6.85 | 6.93 | 6.57 | 8.88 | 6.49 | 6.41 | 5.43 | 5.18 | 5.25 | 3.25 | 3.42 | 3.59 | 3.99 | 7.61 | 7.68 | 7.18 | |
| Inventory | 6.81 | 6.19 | 6.57 | 6.17 | 5.16 | 5.01 | 4.32 | 3.80 | 3.60 | 2.43 | 2.60 | 2.64 | 2.69 | 3.79 | 3.28 | 3.19 | |
| Other Current Assets | 2.23 | 2.57 | 2.26 | 2.66 | 2.35 | 1.87 | 1.79 | 1.57 | 1.69 | 2.32 | 2.01 | 4.57 | 4.47 | 4.74 | 4.70 | 6.49 | |
| Total Current Assets | 23.12 | 23.66 | 22.67 | 25.22 | 24.24 | 20.44 | 15.67 | 14.63 | 20.15 | 26.78 | 14.16 | 15.26 | 19.25 | 31.32 | 23.77 | 22.32 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 6.95 | 6.53 | 7.62 | 7.56 | 6.99 | 6.28 | 6.90 | 6.71 | 7.84 | 9.88 | |
| Short Term Investments | 0.33 | 0.31 | 0.35 | 0.23 | 0.23 | 0.37 | 0.38 | 0.34 | 0.32 | 0.29 | |
| Total Cash & ST Investments | 7.28 | 6.84 | 7.97 | 7.79 | 7.22 | 6.65 | 7.28 | 7.05 | 8.16 | 10.17 | |
| Accounts Receivable | 10.23 | 7.33 | 6.93 | 7.05 | 6.85 | 6.61 | 6.57 | 6.50 | 6.17 | 6.02 | |
| Inventory | 6.95 | 6.64 | 6.19 | 6.81 | 6.81 | 6.83 | 6.57 | 6.65 | 6.87 | 6.17 | |
| Other Current Assets | 0.00 | 2.34 | 2.57 | 2.15 | 2.23 | 2.29 | 4.34 | 2.47 | 2.31 | 2.15 | |
| Total Current Assets | 24.47 | 23.15 | 23.66 | 23.80 | 23.12 | 22.38 | 22.67 | 22.66 | 23.51 | 25.22 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 10.23 | 11.73 | 11.28 | 9.16 | 8.96 | 9.03 | 8.04 | 7.56 | 7.61 | 5.71 | 5.73 | 5.94 | 5.91 | 8.06 | 7.87 | 7.97 | |
| Goodwill | 23.31 | 23.11 | 23.68 | 22.80 | 23.23 | 23.74 | 23.20 | 23.25 | 24.02 | 7.68 | 9.64 | 10.07 | 9.77 | 15.77 | 15.71 | 15.93 | |
| Intangible Assets | 7.83 | 6.65 | 8.82 | 10.45 | 12.74 | 14.78 | 17.03 | 18.94 | 21.47 | 4.54 | 5.56 | 6.20 | 5.74 | 8.59 | 9.99 | 12.15 | |
| Long-Term Investments | 0.88 | 0.89 | 0.80 | 0.77 | 0.82 | 0.82 | 0.88 | 0.90 | 0.88 | 2.95 | 4.04 | 0.23 | 0.12 | 0.27 | 0.38 | 0.30 | |
| Other Long-Term Assets | 0.00 | 15.38 | 5.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.18 | 2.75 | 0.00 | 1.93 | 0.07 | 0.00 | 0.00 | 0.00 | |
| Total Long-Term Assets | 49.90 | 57.76 | 50.54 | 49.21 | 50.96 | 52.11 | 52.22 | 52.54 | 56.10 | 25.89 | 27.09 | 26.01 | 23.71 | 35.91 | 36.51 | 37.14 | |
| Total Assets | 73.02 | 81.41 | 73.21 | 74.44 | 75.20 | 72.55 | 67.89 | 67.17 | 76.25 | 52.67 | 41.25 | 41.28 | 42.95 | 67.23 | 60.28 | 59.46 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 11.40 | 10.93 | 11.73 | 10.62 | 10.23 | 10.11 | 11.28 | 9.55 | 9.45 | 9.16 | |
| Goodwill | 23.95 | 23.36 | 23.11 | 23.66 | 23.31 | 23.38 | 23.68 | 23.28 | 23.26 | 22.80 | |
| Intangible Assets | 5.92 | 6.26 | 6.65 | 7.35 | 7.83 | 8.30 | 8.82 | 9.28 | 9.83 | 10.45 | |
| Long-Term Investments | 0.96 | 0.91 | 0.89 | 0.91 | 0.88 | 0.82 | 0.80 | 0.79 | 0.80 | 0.77 | |
| Other Long-Term Assets | 17.31 | 16.84 | 15.38 | 8.01 | 7.65 | 7.49 | 5.98 | 0.00 | 0.00 | 0.00 | |
| Total Long-Term Assets | 59.53 | 58.30 | 57.76 | 50.55 | 49.90 | 50.09 | 50.54 | 49.43 | 49.85 | 49.21 | |
| Total Assets | 84.00 | 81.45 | 81.41 | 74.36 | 73.02 | 72.47 | 73.21 | 72.09 | 73.35 | 74.44 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.13 | 4.20 | 4.30 | 4.61 | 4.41 | 3.95 | 3.25 | 2.98 | 2.40 | 1.18 | 1.08 | 1.06 | 1.03 | 1.80 | 1.72 | 1.54 | |
| Short-Term Debt | 1.62 | 1.75 | 1.33 | 2.25 | 0.75 | 0.22 | 1.48 | 0.21 | 0.71 | 1.33 | 3.13 | 4.44 | 3.17 | 2.39 | 3.37 | 6.39 | |
| Other Current Liabilities | 7.42 | 7.61 | 7.73 | 8.63 | 7.94 | 7.74 | 6.13 | 5.53 | 5.49 | 3.97 | 4.55 | 4.76 | 5.13 | 8.44 | 9.87 | 8.02 | |
| Current Liabilities | 13.76 | 14.16 | 13.84 | 15.49 | 13.11 | 11.91 | 10.86 | 9.01 | 8.91 | 6.66 | 9.19 | 10.53 | 9.51 | 13.28 | 15.48 | 17.26 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.31 | 4.21 | 4.20 | 4.03 | 4.13 | 4.18 | 4.30 | 3.96 | 4.21 | 4.17 | |
| Short-Term Debt | 0.51 | 0.51 | 1.75 | 2.15 | 1.62 | 2.01 | 1.08 | 1.05 | 2.28 | 2.29 | |
| Other Current Liabilities | 8.24 | 7.80 | 7.61 | 8.00 | 7.42 | 7.27 | 7.97 | 7.71 | 7.58 | 7.74 | |
| Current Liabilities | 13.44 | 13.00 | 14.16 | 14.90 | 13.76 | 14.02 | 13.84 | 13.04 | 14.35 | 15.49 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 13.14 | 13.52 | 14.55 | 15.47 | 18.25 | 19.43 | 17.42 | 19.36 | 27.21 | 20.68 | 5.87 | 3.41 | 3.39 | 18.09 | 12.04 | 12.52 | |
| Capital Leases | 0.00 | 0.90 | 0.95 | 0.94 | 0.96 | 0.90 | 0.76 | 8.08 | 0.00 | 0.00 | 0.00 | 0.00 | 4.78 | 9,056.23 | 8,230.70 | 7,199.85 | |
| Def. Tax Liability | 6.56 | 1.37 | 0.00 | 0.99 | 1.39 | 1.41 | 1.55 | 2.06 | 2.01 | 0.36 | 0.81 | 0.86 | 0.47 | 0.71 | 0.00 | 0.00 | |
| Total Liabilities | 33.46 | 33.51 | 34.39 | 37.53 | 39.17 | 39.55 | 36.59 | 36.45 | 45.15 | 31.95 | 19.92 | 19.64 | 17.69 | 40.42 | 35.75 | 36.99 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 12.93 | 12.74 | 13.52 | 12.83 | 13.14 | 12.58 | 14.55 | 14.48 | 14.56 | 14.62 | |
| Capital Leases | 0.00 | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.95 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 1.37 | 0.00 | 0.00 | 0.00 | 1.22 | 6.88 | 7.04 | 7.52 | |
| Total Liabilities | 33.17 | 32.38 | 33.51 | 34.33 | 33.46 | 33.42 | 34.39 | 34.40 | 35.95 | 36.56 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 24.86 | 25.15 | 24.87 | 24.71 | 24.47 | 24.15 | 23.85 | 23.51 | 23.21 | 13.03 | 12.73 | 12.38 | 12.05 | 11.75 | 9,817.13 | 8,744.70 | |
| Retained Earnings | 38.35 | 47.26 | 37.55 | 35.26 | 31.53 | 27.63 | 25.85 | 24.56 | 23.98 | 25.57 | 25.76 | 22.87 | 21.98 | 24.15 | 20.91 | 18.93 | |
| Comprehensive Income | -8.14 | -7.91 | -7.84 | -8.05 | -8.37 | -8.95 | -8.47 | -7.59 | -6.06 | -7.26 | -6.66 | -5.05 | -2.01 | -3.59 | -2.60 | -1.37 | |
| Total Common Equity | 39.32 | 47.66 | 38.60 | 36.69 | 35.80 | 32.78 | 31.09 | 30.52 | 30.90 | 20.54 | 21.21 | 21.53 | 25.17 | 26.72 | 24.44 | 22.39 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 25.28 | 25.13 | 25.15 | 25.02 | 24.86 | 24.73 | 24.87 | 24.73 | 24.61 | 24.71 | |
| Retained Earnings | 48.47 | 47.72 | 47.26 | 39.06 | 38.35 | 38.01 | 37.55 | 36.92 | 36.36 | 35.87 | |
| Comprehensive Income | -6.58 | -7.42 | -7.91 | -7.80 | -8.14 | -8.17 | -7.84 | -8.48 | -8.07 | -8.05 | |
| Total Common Equity | 50.57 | 48.81 | 47.66 | 39.80 | 39.32 | 38.81 | 38.60 | 37.48 | 37.17 | 74.22 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 14.75 | 15.28 | 15.87 | 17.72 | 19.01 | 19.65 | 18.89 | 19.57 | 27.92 | 22.01 | 9.00 | 7.85 | 6.56 | 20.48 | 15.41 | 18.92 | |
| Book Value | 39.56 | 47.90 | 38.83 | 36.91 | 36.02 | 33.00 | 31.30 | 30.72 | 31.10 | 20.72 | 21.33 | 21.64 | 25.27 | 26.81 | 24.53 | 22.48 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.26 | 0.25 | 0.24 | 0.23 | 0.24 | 0.23 | 0.22 | 0.21 | 0.23 | 0.22 | |
| Book Value | 50.57 | 48.81 | 47.66 | 39.80 | 39.32 | 38.81 | 38.60 | 37.48 | 37.17 | 74.22 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.54 | 6.52 | 13.40 | 5.72 | 6.93 | 7.07 | 4.50 | 3.69 | 2.37 | 0.48 | 1.38 | 1.58 | 2.28 | 2.58 | 5.96 | 4.73 | 4.63 | |
| Depreciation & Amortization | 3.25 | 3.12 | 3.22 | 3.24 | 3.27 | 3.54 | 3.33 | 3.01 | 3.28 | 3.02 | 1.35 | 1.47 | 1.55 | 1.72 | 2.78 | 3.04 | 2.62 | |
| Stock-Based Compensation | 0.68 | 0.66 | 0.67 | 0.64 | 0.69 | 0.64 | 0.55 | 0.52 | 0.48 | 0.41 | 0.31 | 0.29 | 0.25 | 0.26 | 0.43 | 0.38 | 0.39 | |
| Change Working Capital | -1.53 | -0.80 | -9.22 | -2.48 | -1.52 | -0.77 | -0.89 | -1.33 | -0.15 | 1.92 | -1.51 | -0.16 | -0.49 | -1.24 | -1.86 | 0.00 | 0.66 | |
| Change In Accounts Receivable | -0.87 | -0.65 | -0.69 | -0.36 | -0.07 | -0.38 | -0.92 | -0.28 | -0.19 | -0.21 | -0.18 | -0.17 | -0.20 | -0.11 | 0.04 | -0.67 | -0.39 | |
| Change In Accounts Payable | -1.17 | 0.95 | 0.36 | -0.76 | 0.42 | 1.29 | 1.77 | 0.22 | 0.75 | 0.62 | -0.65 | -0.74 | -0.23 | -0.44 | -0.13 | 1.79 | 0.57 | |
| Change In Inventories | -0.08 | 0.20 | -0.06 | -0.23 | -1.41 | -0.46 | -0.49 | -0.59 | -0.51 | 0.25 | -0.10 | -0.26 | -0.30 | -0.15 | -0.42 | -0.13 | 0.14 | |
| Other Non-cash Items | 5.99 | 0.07 | 0.48 | 0.13 | 0.22 | 0.06 | 0.43 | 0.25 | 0.03 | 0.91 | 1.43 | -0.54 | -0.34 | -0.39 | -1,848.46 | -967.94 | -327.97 | |
| Cash from Operations | 7.90 | 0.00 | 0.00 | 7.26 | 9.58 | 10.53 | 7.90 | 6.14 | 6.30 | 5.57 | 3.20 | 2.97 | 3.68 | 3.32 | 9.31 | 8.97 | 8.74 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.78 | 1.64 | 1.78 | 1.33 | 9.23 | 1.65 | 1.30 | 1.23 | 1.59 | 1.44 | |
| Depreciation & Amortization | 0.79 | 0.79 | 0.78 | 0.76 | 0.81 | 0.80 | 0.81 | 0.81 | 0.81 | 0.82 | |
| Stock-Based Compensation | 0.11 | 0.12 | 0.14 | 0.29 | 0.11 | 0.12 | 0.14 | 0.30 | 0.11 | 0.12 | |
| Change Working Capital | 0.57 | 0.23 | -0.65 | -0.95 | -8.39 | 0.16 | -0.43 | -0.56 | 0.39 | -0.32 | |
| Change In Accounts Receivable | 0.22 | -0.20 | -0.41 | -0.26 | -0.16 | -0.06 | -0.33 | -0.15 | 0.07 | -0.46 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.35 | 0.18 | |
| Change In Inventories | 0.23 | 0.21 | 0.00 | -0.26 | 0.24 | 0.22 | -0.10 | -0.41 | 0.30 | 0.14 | |
| Other Non-cash Items | 0.07 | 0.00 | 0.00 | 0.00 | 1.11 | -0.02 | 0.14 | -0.75 | 1.51 | -0.18 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.04 | 1.88 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.25 | -2.17 | -2.21 | -2.20 | -1.78 | -1.89 | -2.18 | -1.64 | -1.39 | -1.14 | -1.12 | -1.11 | -1.08 | -1.15 | -1.80 | -1.49 | -1.02 | |
| Acquisitions | -0.09 | -0.11 | 0.00 | -0.84 | 0.05 | -0.05 | 0.02 | -0.12 | 0.05 | -8.44 | -0.06 | 2.29 | -3.32 | -0.58 | -1.23 | -0.67 | -9.43 | |
| Investments | -0.15 | -0.17 | -0.17 | -0.16 | -0.19 | -0.17 | -0.08 | -0.10 | -0.13 | -0.21 | -2.82 | -4.93 | -1.51 | -10.06 | -12.00 | -5.11 | -0.81 | |
| Sales of Investment | 0.13 | 0.00 | 0.03 | 0.04 | 0.15 | 0.08 | 0.01 | 0.02 | 0.07 | 0.13 | 3.71 | 4.11 | 5.62 | 7.84 | 8.94 | 5.65 | 0.95 | |
| Other Investing Activities | -0.02 | 0.00 | 0.00 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.05 | 0.04 | 0.04 | 0.05 | 0.08 | 0.02 | 0.00 | 1.89 | -1.89 | |
| Cash from Investing | -2.34 | 0.00 | 0.00 | -3.13 | -1.74 | -2.01 | -2.22 | -1.82 | -1.36 | -9.62 | -0.25 | 0.41 | -0.20 | -3.93 | -6.08 | 0.26 | -12.19 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.69 | -0.50 | -0.50 | -0.48 | -0.72 | -0.56 | -0.53 | -0.40 | -0.76 | -0.56 | |
| Acquisitions | -0.05 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | -0.05 | |
| Investments | -0.17 | 0.04 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 | -0.04 | |
| Sales of Investment | -0.04 | 0.05 | -0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.82 | -0.63 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -2.67 | 0.00 | 0.00 | -2.48 | -0.75 | -0.05 | -1.33 | -3.44 | -12.43 | -8.65 | -0.01 | -0.06 | -0.58 | -0.30 | -11.07 | -3.01 | -1.67 | |
| Debt Issued | 0.58 | 15.28 | -0.60 | 0.63 | -0.54 | -0.60 | 2.09 | 2.77 | 4.08 | 14.57 | 13.02 | 1.21 | 1.86 | -13.61 | 16.13 | -0.49 | 20.59 | |
| Issuance of Common Stock | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.53 | 0.00 | 0.00 | 6.06 | 13.42 | 1.52 | 1.77 | 2.49 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.49 | -0.89 | -1.30 | -1.23 | -3.80 | -2.30 | -0.40 | -0.72 | -0.24 | -0.83 | -0.52 | -2.24 | -2.20 | -1.61 | -2.36 | -0.08 | -0.87 | |
| Dividends Paid | -3.69 | 0.00 | 0.00 | -3.56 | -3.31 | -3.20 | -2.56 | -2.27 | -1.97 | -1.85 | -1.54 | -1.44 | -1.34 | -0.88 | -3.18 | -2.94 | -2.67 | |
| Other Financing Activities | 0.26 | 0.00 | 0.00 | 0.17 | 0.22 | 0.06 | -0.01 | 2.14 | 4.25 | -0.01 | -0.20 | -0.02 | -0.40 | -6.40 | 17.33 | 0.00 | 4.12 | |
| Cash from Financing | -6.36 | 0.00 | 0.00 | -7.09 | -7.64 | -5.49 | -2.78 | -4.29 | -10.39 | -5.28 | 11.15 | -2.24 | -2.74 | -6.70 | 0.72 | -6.02 | -1.09 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.94 | -1.51 | |
| Debt Issued | 0.00 | 13.44 | 0.20 | -2.03 | 0.30 | 0.23 | 0.17 | -1.29 | 1.28 | 0.19 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.30 | -0.31 | -0.01 | -0.28 | -0.32 | -0.75 | 0.00 | -0.23 | -0.26 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.89 | -0.89 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.06 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.05 | -2.34 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -0.85 | 0.91 | 0.72 | -2.99 | 0.08 | 2.96 | 2.98 | 0.02 | -5.56 | -9.21 | 13.62 | 0.94 | 0.59 | -7.33 | 3.99 | 3.16 | -5.16 | |
| Closing Cash Balance | 6.99 | 8.52 | 7.62 | 6.90 | 9.88 | 9.80 | 6.84 | 3.86 | 3.84 | 9.41 | 18.62 | 5.00 | 4.06 | 3.48 | 10.80 | 6.81 | 3.65 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1.01 | 0.56 | 0.42 | -1.08 | 0.06 | 0.57 | 0.70 | -0.61 | 0.19 | -1.13 | |
| Closing Cash Balance | 8.52 | 7.51 | 6.95 | 6.53 | 7.62 | 7.56 | 6.99 | 6.28 | 6.90 | 6.71 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.65 | 7.40 | 6.35 | 5.06 | 7.80 | 8.65 | 5.72 | 4.50 | 4.91 | 4.44 | 2.08 | 1.86 | 2.60 | 2.18 | 7.52 | 7.48 | 7.72 | |
| Real Free Cash Flow | 4.98 | 6.73 | 5.68 | 4.42 | 7.12 | 8.01 | 5.18 | 3.98 | 4.43 | 4.03 | 1.77 | 1.56 | 2.35 | 1.92 | 7.09 | 7.10 | 7.33 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.63 | 2.29 | 1.55 | 0.93 | 2.15 | 2.15 | 1.43 | 0.63 | 2.28 | 1.32 | |
| Real Free Cash Flow | 2.51 | 2.17 | 1.40 | 0.64 | 2.04 | 2.03 | 1.29 | 0.32 | 2.17 | 1.20 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 28.3 | 40.6 | 179.3 |
| P/S | 4.2 | 3.9 | 390.6 |
| P/B | 3.6 | 4 | 113.4 |
| P/FCF | 27.4 | 30.3 | 149.9 |
| Market cap | $218.3 | $177.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 24.5 % | 0 % |
| Debt to Income | 206 % | 658.4 % | 0 % |
| Debt to Free cash flow | 199.6 % | 29.1 % | 0 % |
| Interest expense percentage | 4.2 % | 9.8 % | 0 % |
| Current ratio | 1.8 | 1.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 12.9 % | 13.9 % | 0 % |
| ROA | 7.8 % | 6.8 % | 0 % |
| CapEx to Revenue | 4.9 % | 4.5 % | 0 % |
| RaD to Revenue | 0 % | 7.6 % | 0 % |
| ROEM | 388,842.1 | 291259.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 55.5 % | 56.9 % | 0 % |
| Operating margin | 18.2 % | 15.3 % | 0 % |
| Net margin | 14.7 % | 13.6 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2 % | 0 % |
| Dividend payout percentage | 0 % | 72.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 1,747.0 mil | 1,668.0 mil |
| Employee count | 114.0 tis | 77.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
